Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: A case-control study

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Bagheri Hanson, Azadeh ^a   Nedwed, Sebastian ^a   Rueckes Nilges, Claudia ^a   Naehrlich, Lutz ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

(3 10): Cystic fibrosis; Diagnosis; Intestinal current measurement; Nasal potential difference; Smoking; Sweat chloride; Sweat test

Indexed keywords

CARBACHOL; CHLORIDE; FORSKOLIN; HISTAMINE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINAL CURRENT MEASUREMENT; MALE; NASAL POTENTIAL DIFFERENCE; PANCREAS INSUFFICIENCY; RECTUM BIOPSY; SHORT CIRCUIT CURRENT; SMOKING; SWEAT TEST; CASE CONTROL STUDY; CHEMISTRY; CHILD; COMPARATIVE STUDY; GENETICS; INTESTINE MUCOSA; METABOLISM; NOSE; PATHOPHYSIOLOGY; PHYSIOLOGY; RECTUM; RESPIRATORY TRACT MUCOSA; SWEAT; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; NOSE; RECTUM; RESPIRATORY MUCOSA; SMOKING; SWEAT; YOUNG ADULT;

EID: 84908069345     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-156     Document Type: Article

References (44)

1. De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, Sinaasappel M. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006, 61(7):627-635. 10.1136/thx.2005.043539, 2104676, 16384879.
2. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008, 153(2):S4-S14. 10.1016/j.jpeds.2008.05.005, 2810958, 18639722.
3. Gonska T, Choi P, Stephenson A, Ellis L, Martin S, Solomon M, Dupuis A, Dorfman R, Zielenski J, Ooi CY, Weiser W, Durie PR, Tullis E. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease. Chest 2012, 142(4):996-1004. 10.1378/chest.11-2543, 22423042.
4. Ooi CY, Dupuis A, Ellis L, Jarvi K, Martin S, Ray PN, Steele L, Kortan P, Gonska T, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, Durie P. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?. Thorax 2014, 69(3):254-260. 10.1136/thoraxjnl-2013-203832, 24149827.
5. Segal I, Yaakov Y, Adler SN, Blau H, Broide E, Santo M, Yahav Y, Klar A, Lerner A, Aviram M, Ellis I, Mountford R, Shteyer E, Kerem E, Wilschanski M. Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis. J Clin Gastroenterol 2008, 42(7):810-814. 10.1097/MCG.0b013e318156617c, 18360295.
6. Ooi CY, Dupuis A, Ellis L, Jarvi K, Martin S, Gonska T, Dorfman R, Kortan P, Solomon M, Tullis E, Durie PR. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?. Thorax 2012, 67(7):618-624. 10.1136/thoraxjnl-2011-201454, 22504961.
7. De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I. CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J 2013, 41(1):203-216. 10.1183/09031936.00057512, 22878883.
8. Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol 2011, 741:69-86. 10.1007/978-1-61779-117-8_6, 3760477, 21594779.
9. Hug MJ, Derichs N, Bronsveld I, Clancy JP. Measurement of ion transport function in rectal biopsies. Methods Mol Biol 2011, 741:87-107. 10.1007/978-1-61779-117-8_7, 21594780.
10. Derichs N, Pinders-Kessler L, Bronsveld I, Scheinert S, Rückes-Nilges C, de Jonge H, Nährlich L. Multicenter European Standardization and reference values for intestinal current measurement in rectal biopsies. Pediatr Pulmonol 2013, 48(S36):300.
11. Sousa M, Servidoni MF, Vinagre AM, Ramalho AS, Bonadia LC, Felicio V, Ribeiro MA, Uliyakina I, Marson FA, Kmit A, Cardoso SR, Ribeiro JD, Bertuzzo CS, Sousa L, Kunzelmann K, Ribeiro AF, Amaral MD. Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis. PLoS One 2012, 7(10):e47708. 10.1371/journal.pone.0047708, 3474728, 23082198.
12. Derichs N, Sanz J, Von Kanel T, Stolpe C, Zapf A, Tummler B, Gallati S, Ballmann M. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data. Thorax 2010, 65(7):594-599. 10.1136/thx.2009.125088, 20627915.
13. Liu B, Hathorne H, Hill A, Cohen M. J. B., Solomon MG, Calancy JP, Rowe SM: Normative values and receiver operating characteristics of NPD for diagnostic measurements. Pediatr Pulmonol 2010, 303(S33):307.
14. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995, 6(4):445-455. 10.1089/hum.1995.6.4-445, 7542031.
15. Hirtz S, Gonska T, Seydewitz HH, Thomas J, Greiner P, Kuehr J, Brandis M, Eichler I, Rocha H, Lopes AI, Barreto C, Ramalho A, Amaral MD, Kunzelmann K, Mall M. CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 2004, 127(4):1085-1095. 10.1053/j.gastro.2004.07.006, 15480987.
16. Cohen-Cymberknoh M, Yaakov Y, Shoseyov D, Shteyer E, Schachar E, Rivlin J, Bentur L, Picard E, Aviram M, Israeli E, Kerem E, Wilschanski M. Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis. Pediatr Pulmonol 2013, 48(3):229-235. 10.1002/ppul.22586, 22553157.
17. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 2006, 173(10):1139-1144. 10.1164/rccm.200508-1330OC, 16497995.
18. Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, Jones CW, Boydston JA, Clancy JP, Bowen LE, Accurso FJ, Blalock JE, Dransfield MT, Rowe SM. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med 2013, 188(11):1321-1330. 10.1164/rccm.201304-0733OC, 24040746.
19. Clinical and Laboratory Standards Institute Sweat Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline-Third Edition, Volume CLSI document C34-A3 2009, Wayne, PA, USA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
20. Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, Klar A, Ilani A, Kerem B, Kerem E. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001, 17(6):1208-1215. 10.1183/09031936.01.00092501, 11491166.
21. Alton EW, Currie D, Logan-Sinclair R, Warner JO, Hodson ME, Geddes DM. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J 1990, 3(8):922-926.
22. Sauder RA, Chesrown SE, Loughlin GM. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J Pediatr 1987, 111(3):353-358. 10.1016/S0022-3476(87)80453-5, 2442338.
23. Middleton PG, House HH. Measurement of airway ion transport assists the diagnosis of cystic fibrosis. Pediatr Pulmonol 2010, 45(8):789-795. 10.1002/ppul.21253, 20597077.
24. Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, Martin S, Corey M, Tsui LC, Durie P. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Respir Crit Care Med 2006, 174(7):787-794. 10.1164/rccm.200509-1377OC, 2648063, 16840743.
25. Walker LC, Venglarik CJ, Aubin G, Weatherly MR, McCarty NA, Lesnick B, Ruiz F, Clancy JP, Sorscher EJ. Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR. Am J Respir Crit Care Med 1997, 155(5):1684-1689. 10.1164/ajrccm.155.5.9154877, 9154877.
26. Bronsveld I, Mekus F, Bijman J, Ballmann M, de Jonge HR, Laabs U, Halley DJ, Ellemunter H, Mastella G, Thomas S, Veeze HJ, Tummler B. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest 2001, 108(11):1705-1715. 10.1172/JCI12108, 200980, 11733566.
27. Leal T, Fajac I, Wallace HL, Lebecque P, Lebacq J, Hubert D, Dall'Ava J, Dusser D, Ganesan AP, Knoop C, Cumps J, Wallemacq P, Southern KW. Airway ion transport impacts on disease presentation and severity in cystic fibrosis. Clin Biochem 2008, 41(10-11):764-772.
28. Wallace HL, Barker PM, Southern KW. Nasal airway ion transport and lung function in young people with cystic fibrosis. Am J Respir Crit Care Med 2003, 168(5):594-600. 10.1164/rccm.200211-1302OC, 12829453.
29. Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tummler B, Vermeulen F, Wilschanski M. Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey. J Cyst Fibros 2014, 13(1):24-28. 10.1016/j.jcf.2013.08.006, 24022019.
30. Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. Am J Respir Crit Care Med 2010, 182(7):929-936. 10.1164/rccm.201003-0382OC, 20538955.
31. Veeze HJ, Halley DJ, Bijman J, de Jongste JC, de Jonge HR, Sinaasappel M. Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype. J Clin Invest 1994, 93(2):461-466. 10.1172/JCI116993, 293855, 8113384.
32. De Jonge HR, Ballmann M, Veeze H, Bronsveld I, Stanke F, Tummler B, Sinaasappel M. Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers. J Cyst Fibros 2004, 3(Suppl 2):159-163.
33. Veeze HJ, Sinaasappel M, Bijman J, Bouquet J, de Jonge HR. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenterology 1991, 101(2):398-403.
34. Clancy JP, Szczesniak RD, Ashlock MA, Ernst SE, Fan L, Hornick DB, Karp PH, Khan U, Lymp J, Ostmann AJ, Rezayat A, Starner TD, Sugandha SP, Sun H, Quinney N, Donaldson SH, Rowe SM, Gabriel SE. Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. PLoS One 2013, 8(9):e73905. 10.1371/journal.pone.0073905, 3769519, 24040112.
35. Hogenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet 2000, 67(6):1422-1427. 10.1086/316911, 1287919, 11055897.
36. Kalin N, Claass A, Sommer M, Puchelle E, Tummler B. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 1999, 103(10):1379-1389. 10.1172/JCI5731, 408454, 10330420.
37. van Meegen MA, Terheggen-Lagro SW, Koymans KJ, van der Ent CK, Beekman JM. Apical CFTR expression in human nasal epithelium correlates with lung disease in cystic fibrosis. PLoS One 2013, 8(3):e57617. 10.1371/journal.pone.0057617, 3590182, 23483918.
38. van Barneveld A, Stanke F, Tamm S, Siebert B, Brandes G, Derichs N, Ballmann M, Junge S, Tummler B. Functional analysis of F508del CFTR in native human colon. Biochim Biophys Acta 2010, 1802(11):1062-1069. 10.1016/j.bbadis.2010.08.001, 20696241.
39. Greger R. Role of CFTR in the colon. Annu Rev Physiol 2000, 62:467-491. 10.1146/annurev.physiol.62.1.467, 10845099.
40. Chilvers MA, McKean M, Rutman A, Myint BS, Silverman M, O'Callaghan C. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J 2001, 18(6):965-970. 10.1183/09031936.01.00093001, 11829103.
41. Yeo NK, Jang YJ. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells. Laryngoscope 2010, 120(2):346-352.
42. Brezillon S, Dupuit F, Hinnrasky J, Marchand V, Kalin N, Tummler B, Puchelle E. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest 1995, 72(2):191-200.
43. Knowles M, Murray G, Shallal J, Askin F, Ranga V, Gatzy J, Boucher R. Bioelectric properties and ion flow across excised human bronchi. J Appl Physiol 1984, 56(4):868-877.
44. Servidoni MF, Sousa M, Vinagre AM, Cardoso SR, Ribeiro MA, Meirelles LR, de Carvalho RB, Kunzelmann K, Ribeiro AF, Ribeiro JD, Amaral MD. Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility. BMC Gastroenterol 2013, 13(1):91. 10.1186/1471-230X-13-91, 3679995, 23688510.